Autobahn Therapeutics receives US FDA fast track designation for Elunetirom for adjunctive treatment of bipolar depression: San Diego Thursday, May 28, 2026, 16:00 Hrs [IST] Autob ...

LifeArc, the self-funded UK medical research organisation turning promising science into patient impact, with a focus on rare diseases and drug-resistant infections, has announced a new partnership ...

Lupin Limited (Lupin), a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets, announced that results from its phase 1a trial evaluating LNP8701, ...

MetrioPharm AG, a clinical-stage biotechnology company developing medicines for inflammatory and infectious diseases, announced that Prof. Dr. med. Jürgen Braun is joining the company’s Scientific ...

Tata Elxsi, a global leader in design and technology services, today announced the launch of AnaTel, an AI-native software development platform for healthcare and medical technology companies, ...

Nutrify Today’s Sumflex platform has entered a new phase of global expansion with the launch of Nutrify Today Eurasia Sumflex in Tashkent from May 20 to May 22, 2026, marking Uzbekistan’s emergence as ...

Natera, Inc., a global leader in cell-free DNA (cfDNA) testing and precision medicine, announced a major enhancement to its Panorama non-invasive prenatal test (NIPT). Powered by the company’s novel ...

Remidio Innovative Solutions has won First Place under the Point of Care Devices category at the Andhra Pradesh MedTech Innovation Challenge, announced at the programme's grand finale today during the ...

The Lupus Research Alliance (LRA), the world’s largest private funder of lupus research, in collaboration with Genentech, a member of the Roche Group, announced the inaugural recipients of the Lupus ...

Member States at the Seventy-ninth World Health Assembly (WHA79) adopted the updated Global action plan on antimicrobial resistance (GAP-AMR) 2026–2036, marking a major milestone in the global ...

GSK plc will present new data from its expanding oncology portfolio and pipeline at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting (29 May - 2 June) in Chicago, IL and the 31st ...

Biocytogen, a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, announced the launch of RenSuper Workstation, a ...